DUBLIN, June 18, 2020 /PRNewswire/ -- The "Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The stem cell therapy market was valued at US$ 1,534.55 million in 2019 and is estimated to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.

The increasing awareness related to the stem cells therapy in effective disease management and growing demand for regenerative medicines are the key factor driving the stem cell therapy market. However, high cost related of the stem cell therapy limits the growth of the market.

Stem cell research has been widely investigated globally for various medical applications, especially for the treatment of humans. This raises the importance of creating public awareness about stem cell research and its clinical potential. The main role of stem cells is in the replacement of dying cells and reconstruction of damaged tissues. Based on the extensive stem cell research, many scientists have claimed that these cells could probably be used in the treatment of various diseases, including cancer and cardiovascular disease.

There is a large number of potential treatment procedures that are undergoing clinical trials, and a notably few stem cell therapies have won FDA (i.e., US -Food and Drug Administration) approval for clinical usage. For instance, in 2019, the FDA approved Fedratinib for the first-line treatment for myelofibrosis. Moreover, stem cell therapies are widely used in bone marrow transplantation, and these therapies have benefited thousands of people suffering from leukemia. Hematopoietic stem cells are used for treating more than 80 medical diseases, including immune system disorders, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and several types of cancers, such as leukemia and lymphoma; this is also likely to boost the demand for this treatment procedure during the forecast period. Researchers are further investigating the use of stem cell therapies in the treatment of autoimmune disorders.

The global stem cell therapy market has been segmented on the basis of type, treatment, application type, and end user. Based on type, the market has been segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and others. The adult stem cell therapy held the largest share of the market in 2019; however, induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market during the forecast period. Based on treatment, the stem cell therapy market has been segmented into allogeneic and autologous. The allogeneic segment held a larger share of the market in 2019; however, the market for the autologous segment is expected to grow at a higher CAGR during the forecast period.

Reasons to Buy:

Key Topics Covered:

1. Introduction 1.1 Scope of the Study 1.2 Report Guidance 1.3 Market Segmentation 1.3.1 Global Stem Cell Therapy Market - By Type 1.3.2 Global Stem Cell Therapy Market - By Treatment 1.3.3 Global Stem Cell Therapy Market - By Application 1.3.4 Global Stem Cell Therapy Market - By End User 1.3.5 Global Stem Cell Therapy Market - By Geography

2. Stem Cell Therapy Market - Key Takeaways

3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research

4. Stem Cell Therapy - Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America 4.2.2 Europe 4.2.3 Asia Pacific 4.2.4 Middle East & Africa 4.2.5 South and Central America 4.3 Expert Opinion

5. Stem Cell Therapy Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management 5.1.2 Growing Demand For Regenerative Medicines 5.1.3 Growing Cancer Prevalence Across The Globe 5.2 Market Restraints 5.2.1 High Cost Related with Stem Cell Therapy 5.3 Market Opportunities 5.3.1 Growth in the Global Healthcare Market 5.4 Future Trends 5.4.1 Research Activities and Product Innovations 5.5 Impact Analysis

6. Stem Cell Therapy Market - Global Analysis 6.1 Global Stem Cell Therapy Market Revenue Forecast And Analysis 6.2 Global Stem Cell Therapy Market, By Geography - Forecast And Analysis 6.3 Market Positioning of Key Players

7. Global Stem Cell Therapy Market Analysis- by Type 7.1 Overview 7.2 Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027) 7.3 Adult Stem Cell Therapy 7.3.1 Overview 7.3.2 Adult Stem Cell Therapy : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.3 Hematopoietic Stem Cell Therapy 7.3.3.1 Overview 7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.4 Umbilical Cord Stem Cell Therapy 7.3.4.1 Overview 7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.5 Neuronal Stem Cell Therapy 7.3.5.1 Overview 7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.6 Mesenchymal Stem Cell 7.3.6.1 Overview 7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4 Induced Pluripotent Stem Cell Therapy 7.4.1 Overview 7.4.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4.3 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.5 Embryonic Stem Cell Therapy 7.5.1 Overview 7.5.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.6 Other Stem Cell Therapy 7.6.1 Overview 7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Stem Cell Therapy Market Analysis- by Treatment 8.1 Overview 8.2 Stem Cell Therapy Market, by Treatment 2019 and 2027 (%) 8.3 Allogeneic 8.3.1 Overview 8.3.2 Allogeneic: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 8.4 Autologous 8.4.1 Overview 8.4.2 Autologous: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Stem Cell Therapy Market Analysis - by Application 9.1 Overview 9.2 Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027) 9.3 Musculoskeletal 9.3.1 Overview 9.3.2 Musculoskeletal: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.4 Dermatology 9.4.1 Overview 9.4.2 Dermatology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.5 Cardiology 9.5.1 Overview 9.5.2 Cardiology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.6 Drug Discovery and Development 9.6.1 Overview 9.6.2 Drug Discovery and Development: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.7 Other Applications 9.7.1 Overview 9.7.2 Other Applications: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Stem Cell Therapy Market Analysis- by End User 10.1 Overview 10.2 Stem Cell Therapy Market, by End User 2019 and 2027 (%) 10.3 Academic & Research Institutes 10.3.1 Overview 10.3.2 Academic & Research Institutes: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.4 Hospitals & Specialty Clinics 10.4.1 Overview 10.4.2 Hospitals & Specialty Clinics : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Stem Cell Therapy Market - Geographic Analysis 11.1 North America: Stem Cell Therapy Market 11.2 Europe: Stem Cell Therapy Market 11.3 Asia Pacific: Stem Cell Therapy Market 11.4 Middle East & Africa: Stem Cell Therapy Market 11.5 South and Central America: Stem Cell Therapy Market

12. Stem Cell Therapy Market -Industry Landscape 12.1 Overview 12.2 Growth Strategies In The Stem Cell Therapy Market, 2015-2019 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview

13. COMPANY PROFILES 13.1 MEDIPOST 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Pharmicell Co., Inc. 13.3 RichSource 13.4 BioTime Inc. (Lineage Cell Therapeutics, Inc.) 13.5 Mesoblast Limited 13.6 Holostem Terapie Avanzate Srl 13.7 U.S. Stem Cell, Inc. 13.8 Caladrius Biosciences, Inc. 13.9 TiGenix NV 13.10 AlloSource

For more information about this report visit https://www.researchandmarkets.com/r/m8jwr5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the original post:
Worldwide Stem Cell Therapy Industry to 2027 - Growth in the Global Healthcare Market Presents Opportunities - PRNewswire